High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils
High-grade serious ovarian cancer (HGSOC) is an aggressive malignancy that remains refractory to current immunotherapies. While advanced stage disease has been extensively studied, the cellular and molecular mechanisms that promote early immune escape in HGSOC remain largely unexplored. Here, we rep...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2024-12-01
|
| Serier: | OncoImmunology |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2411070 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
